人参炔醇重塑巨噬细胞表型调控乳腺癌细胞生物学行为

邵琦, 李佳丽, 周李宁, 苏兆亮, 许化溪

江苏大学学报(医学版) ›› 2019, Vol. 29 ›› Issue (04) : 287-292.

PDF(2743 KB)
中国科技核心期刊
中国应用型核心期刊
中国医药卫生核心期刊
中国高校优秀科技期刊
美国《化学文摘(CA)》收录
美国《剑桥科学文摘(CSA)》收录
波兰《哥白尼索引(IC)》收录
日本科学技术振兴机构数据库(JST)收录
PDF(2743 KB)
江苏大学学报(医学版) ›› 2019, Vol. 29 ›› Issue (04) : 287-292.
基础医学

人参炔醇重塑巨噬细胞表型调控乳腺癌细胞生物学行为

  • 邵琦, 李佳丽, 周李宁, 苏兆亮, 许化溪
作者信息 +

Effect of panaxynol on the biological behavior of breast cancer cells by remodeling macrophage phenotype

  • SHAO Qi, LI Jia-li, ZHOU Li-ning, SU Zhao-liang, XU Hua-xi
Author information +

摘要

目的:  探讨人参炔醇对巨噬细胞表型和功能的调控作用及对乳腺癌细胞生物学行为的影响。方法: 用人参炔醇处理4T1乳腺癌细胞,观察各项生物学行为变化;用4T1乳腺癌细胞培养上清液预处理RAW264.7 巨噬细胞系48 h,诱导其向M2型巨噬细胞极化;极化后的巨噬细胞再分别经不同浓度人参炔醇(0,8,16 μg/mL)处理24 h,用qRTPCR、蛋白质印迹、流式细胞术、ELISA法联合检测各组表型、抗原递呈相关分子MHCⅡ类分子、CD80、CD86表达改变、分泌谱变化,以及细胞系迁移、侵袭等。结果:  与0 μg/mL组相比,乳腺癌细胞系经8,16 μg/mL人参炔醇处理后,细胞增殖率明显降低(P均<0.01),细胞凋亡率明显增加(P均<0.05),癌细胞趋化作用减弱; M2型巨噬细胞经16 μg/mL人参炔醇刺激后,细胞表型逆转,Arg1表达明显降低(P均<0.01),iNOS表达明显增加(P均<0.01),MHCⅡ、CD80、CD86表达升高;并伴随IL1β、TNFα表达升高(P均<0.01),IL4、IL8、IL10表达降低(P均<0.05);经人参炔醇处理的巨噬细胞能够明显减少乳腺癌细胞的迁移与侵袭。结论: 人参炔醇可重塑巨噬细胞表型和功能,从而间接改变乳腺癌细胞生物学行为。

Abstract

Objective: To investigate the effects of panaxynol on the phenotype and function of macrophages and the biological behavior of breast cancer cells. Methods: Firstly, breast cancer 4T1 cells were directly treated with panaxynol, and various biological behavior changes were observed. Secondly, the macrophage cell line RAW264.7 was stimulated with breast cancer cell 4T1 culture supernatant for 48 h to induce macrophage polarization to M2 macrophages, and then macrophages were treated with different concentrations of panaxynol(0, 8, 16 μg/mL) for 24 h. qRTPCR, Western blotting, flow cytometry and ELISA were used to detect the phenotypic and antigenpresenting related molecules expression changes, such as MHCⅡ, CD80 and CD86, and the secretion spectrum changes, and the influence of panaxynol on the migration and invasion of breast cancer cell lines. Results: Compared with the 0 μg/mL group, the breast cancer cells proliferation was inhibited by the treatment with 8, 16 μg/mL panaxynol(P<0.01), the cell apoptosis rate was enhanced(P<0.05), and the chemotaxis of cancer cells was weakened. In addition, panaxynolstimulated macrophage showed the M2 phenotype. After stimulation with panaxynol(16 μg/mL), the macrophage phenotype was reversed, the expression of Arg1 was decreased(P<0.01), while the expression of iNOS was increased(P<0.01), and the surface antigenpresenting molecules(MHCⅡ, CD80, CD86) was increased significantly, accompanied by the expression level of IL4, IL8, IL10 downregulated(P<0.01) and IL1β, TNFα upregulated(all P<0.05). In addition, panaxynolstimulated macrophages could significantly reduce the number of migrating and invading breast cancer cells. Conclusion: Panaxynol could remodel macrophage phenotype and function, and therefore regulate the biological behavior of breast cancer cells.

关键词

参炔醇 / 巨噬细胞 / 乳腺癌 / 极化 / 肿瘤细胞 / 细胞增殖 / 细胞凋亡

引用本文

导出引用
邵琦, 李佳丽, 周李宁, 苏兆亮, 许化溪. 人参炔醇重塑巨噬细胞表型调控乳腺癌细胞生物学行为[J]. 江苏大学学报(医学版), 2019, 29(04): 287-292
SHAO Qi, LI Jia-li, ZHOU Li-ning, SU Zhao-liang, XU Hua-xi. Effect of panaxynol on the biological behavior of breast cancer cells by remodeling macrophage phenotype[J]. Journal of Jiangsu University(Medicine Edition), 2019, 29(04): 287-292

参考文献

[1]Dong D, Zhang G, Yang J, et al. The role of iron metabolism in cancer therapy focusing on tumorassociated macrophagesJ. J Cell Physiol, 2019,234(6):8028-8039.
[2]Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancerJ. Nat Rev Drug Discov, 2018,17(12):887-904.
[3]Yamaguchi T, Fushida S, Yamamoto Y, et al. Tumorassociated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal disseminationJ. Gastric Cancer, 2016, 19(4): 1052-1065.
[4]Medrek C, Ponten F, Jirstrom K, et al. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patientsJ. BMC Cancer, 2012, 12: 306.
[5]Gupta V, Yull F, Khabele D. Bipolar tumorassociated macrophages in ovarian cancer as targets for therapyJ. Cancers (Basel), 2018, 10(10). pii: E366.
[6]Sharda DR, Yu S, Ray M, et al. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinaseJ. J Immunol, 2011, 187(5): 2181-2192.
[7]Hanahan D, Weinberg RA. Hallmarks of cancer: the next generationJ. Cell, 2011,144(5): 646-674.
[8]Ho MY, Tang SJ, Chuang MJ, et al. TNFα induces epithelialmesenchymal transition of renal cell carcinoma cells via a GSK3βdependent mechanismJ. Mol Cancer Res, 2012, 10(8): 1109-1119.
[9]段贤春, 汪永忠, 居靖. 人参炔醇研究进展J. 安徽医药, 2008, 12(1):1-3.
[10]Le HT, Nguyen HT, Min HY, et al. Corrigendum to “Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and nonstem cells”Canc.Lett.412(2018)297307.J. Cancer Lett, 2018, 424: 136.
[11]Yan Z, Yang R, Jiang Y, et al. Induction of apoptosis in human promyelocytic leukemia HL60 cells by panaxynol and panaxynolJ. Molecules, 2011, 16(7): 5561-5573.
[12]Kim JY, Lee K, Kim SH, et al. Inhibitory effect of tumor cell proliferation and induction of G2/M cell cycle arrest by panaxytriolJ. Planta Medica, 2002, 68(2):119-122.
[13]Sharda DR, Yu S, Ray M, et al. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinaseJ. J Immunol, 2011, 187(5):2181-2192.
[14]Ding M, Fu X, Tan H, et al. The effect of vascular endothelial growth factor C expression in tumorassociated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancerJ. Mol Med Rep, 2012, 6(5):1023-1029.
[15]Afik R, Zigmond E, Vugman M, et al. Tumor macrophages are pivotal constructors of tumor collagenous matrixJ. J Exp Med, 2016, 213(11): 2315-2331.
[16]Ashkar AA, Gillgrass A, Krneta T. The influence of macrophages and the tumor microenvironment on natural killer cellsJ. Curr Mol Med, 2013, 13(1):68-79.
[17]Huang Z, Yang Y, Jiang Y, et al. Antitumor immune responses of tumorassociated macrophages via tolllike receptor 4 triggered by cationic polymersJ. Biomaterials, 2013, 34(3):746-755.
[18]Yang H, Kim C, Kim MJ, et al. Soluble vascular endothelial growth factor receptor3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancerJ. Mol Cancer, 2011, 10: 36.
 

基金

 江苏省社会发展项目(BE2016716);江苏省高校重点实验项目(16KJA320005)


PDF(2743 KB)

50

Accesses

0

Citation

Detail

段落导航
相关文章

/